Robert Cunningham

Bob is responsible for Valisure’s corporate alliances and strategic planning activities. He is the past Director of Platform Development at the Wyss Institute at Harvard University, where he was responsible for the implementation of commercialization and technology translation strategies. His industry experience with Haemonetics, endoVia Medical, RainDance Technologies, and Hemocell includes founder, CEO and other executive roles in companies commercializing innovative technologies. He holds a degree in Biochemistry from the University of California at San Diego and is a member of the Massachusetts Biotechnology Industry Council.